Literature DB >> 18220658

Cardiac and metabolic consequences of aerobic exercise training in experimental diabetes.

Christine Saraceni1, Tom L Broderick.   

Abstract

The experimental literature of the foregoing decade has furnished an assemblage of mechanisms explaining the metabolic perturbations and overall decline in cardiac performance implicated in the pathogenesis of diabetes mellitus. Particularly, the experimentally-induced diabetic rat model has been indispensable in the examination of diabetic cardiomyopathy, an entity distinctly separable from atherosclerosis, hypertension, coronary artery disease and valvular dysfunction, yet convincingly attributable to the increase in cardiac-associated mortality commonly observed in the diabetic patient. The widespread epidemic of diabetes mellitus in developed societies has elicited considerable attention and the role of exercise as an adjuvant therapy in diabetes management has been increasingly emphasized. However, the evidence endorsing the beneficial attributes of exercise in the diabetic state is indeterminate despite markedly observed increases in myocardial and skeletal muscle glucose homeostasis, endothelial and autonomic function, insulin sensitivity and amelioration of diabetes pathogenesis. As evidenced by review of the experimental literature, a mild to moderately intense exercise regime may be a reliably implicated insulin-sensitizing therapy for the experimentally-diabetic rat model as well as the human diabetic patient. Notably, the cardio-protective and metabolic benefits of aerobic exercise are seemingly more pronounced in those individuals most susceptible to diabetes progression.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18220658     DOI: 10.2174/157339907779802111

Source DB:  PubMed          Journal:  Curr Diabetes Rev        ISSN: 1573-3998


  7 in total

Review 1.  Drosophila as a model for age-related impairment in locomotor and other behaviors.

Authors:  Melanie A Jones; Mike Grotewiel
Journal:  Exp Gerontol       Date:  2010-08-26       Impact factor: 4.032

2.  Exercise training during diabetes attenuates cardiac ryanodine receptor dysregulation.

Authors:  Chun-Hong Shao; Xander H T Wehrens; Todd A Wyatt; Sheeva Parbhu; George J Rozanski; Kaushik P Patel; Keshore R Bidasee
Journal:  J Appl Physiol (1985)       Date:  2009-01-08

3.  Effects of moderate exercise on biochemical, morphological, and physiological parameters of the pancreas of female mice with estrogen deprivation and dyslipidemia.

Authors:  Aparecida Gabriela Bexiga Veloso; Nathalia Edviges Alves Lima; Elisabete de Marco Ornelas; Clever Gomes Cardoso; Mara Rubia Marques; Beatriz da Costa Aguiar Alves Reis; Fernando Luiz Affonso Fonseca; Laura Beatriz Mesiano Maifrino
Journal:  Med Mol Morphol       Date:  2018-01-15       Impact factor: 2.309

4.  Effects of varying intensity exercise on shortening and intracellular calcium in ventricular myocytes from streptozotocin (STZ)-induced diabetic rats.

Authors:  Frank Christopher Howarth; F A Almugaddum; M A Qureshi; M Ljubisavljevic; M Ljubisavijevic
Journal:  Mol Cell Biochem       Date:  2008-06-16       Impact factor: 3.396

5.  Modeling exercise using optogenetically contractible Drosophila larvae.

Authors:  Arpan C Ghosh; Yanhui Hu; Sudhir Gopal Tattikota; Yifang Liu; Aram Comjean; Norbert Perrimon
Journal:  BMC Genomics       Date:  2022-08-30       Impact factor: 4.547

6.  Exercise-training in young Drosophila melanogaster reduces age-related decline in mobility and cardiac performance.

Authors:  Nicole Piazza; Babina Gosangi; Shawn Devilla; Robert Arking; Robert Wessells
Journal:  PLoS One       Date:  2009-06-11       Impact factor: 3.240

7.  Resveratrol is not as effective as physical exercise for improving reproductive and metabolic functions in rats with dihydrotestosterone-induced polycystic ovary syndrome.

Authors:  Anna Benrick; Manuel Maliqueo; Sun Miao; Jesus A Villanueva; Yi Feng; Claes Ohlsson; Antoni J Duleba; Elisabet Stener-Victorin
Journal:  Evid Based Complement Alternat Med       Date:  2013-04-08       Impact factor: 2.629

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.